Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF7 | hg38_v1_chr5_+_134142179_134142194 | -0.61 | 2.0e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_132866948 Show fit | 2.93 |
ENST00000220616.9
|
thyroglobulin |
|
chr17_+_70104848 Show fit | 2.54 |
ENST00000392670.5
|
potassium inwardly rectifying channel subfamily J member 16 |
|
chr12_+_78863962 Show fit | 2.45 |
ENST00000393240.7
|
synaptotagmin 1 |
|
chr4_-_185761562 Show fit | 2.23 |
ENST00000445343.5
|
sorbin and SH3 domain containing 2 |
|
chr6_+_112087576 Show fit | 2.09 |
ENST00000368656.7
ENST00000604268.1 |
family with sequence similarity 229 member B |
|
chr2_+_233712905 Show fit | 2.08 |
ENST00000373414.4
|
UDP glucuronosyltransferase family 1 member A5 |
|
chr17_+_32928126 Show fit | 2.03 |
ENST00000579849.6
ENST00000578289.5 ENST00000439138.5 |
transmembrane protein 98 |
|
chr17_+_32927910 Show fit | 2.02 |
ENST00000394642.7
|
transmembrane protein 98 |
|
chr14_+_32329256 Show fit | 2.02 |
ENST00000280979.9
|
A-kinase anchoring protein 6 |
|
chr1_-_151372683 Show fit | 1.98 |
ENST00000458566.5
ENST00000447402.7 ENST00000426705.6 ENST00000368868.10 |
selenium binding protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 2.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 2.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 2.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 2.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 2.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 2.2 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 2.1 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 2.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 5.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 4.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 3.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 2.9 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 2.7 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 2.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 2.4 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 2.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 2.0 | GO:0045179 | apical cortex(GO:0045179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 5.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 3.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 3.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 3.1 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 2.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 2.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 2.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 2.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 2.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 2.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 2.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 3.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 2.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 2.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 2.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 2.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 2.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 2.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 2.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |